Cancer immunotherapy: - A pan-cancer program

Research Research programs Cancer immunotherapy:

Our purpose

We aim to unravel the underlying mechanisms of tumor-immune attack and resistance in a wide variety of cancer types and contribute to better clinical outcomes of cancer patients treated with immunotherapy.

Goals

See some of the most important goals for this research program.

Listen

Goals

Build a solid interdisciplinary network for cancer immunotherapy research within the Radboudumc.
Unravel the underling mechanisms of the tumor-immune attack and resistance.
Improve the use of current available immunotherapies.
Develop new immunotherapeutic strategies for clinical application.

Research groups contributing to this research program

Computational immunology

Johannes Textor's research group studies the adaptive immune system, and its response to cancer, using computational tools such as simulations, machine learning algorithms, and artificial intelligence.

Experimental immunology

Annemiek van Spriel's research group studies the immune system at the cellular and molecular level.

Immune dysregulation in hematologic malignancies

Willemijn Hobo's research group focuses on deciphering mechanisms underlying immune dysfunction in cancer patient and development of novel therapeutic approaches to (re)establish immune-mediated tumor control.

Spokesperson

dr. Kalijn Bol

contact form

Spokesperson

prof. dr. Jolanda de Vries

contact form